Omrix's Unattributed VC - II Round

Omrix raised a round of funding on April 19, 1999. Investors include MPM Capital.

Omrix is a fully integrated biopharmaceutical company that develops, manufactures and markets protein-based biosurgery and passive immunotherapy products. Omrix's biosurgery product line includes prod…

Articles about Omrix's Unattributed VC - II Round: